NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ

Figure 9

A schematic illustration of plausible mechanisms by which FTZ inhibits the NLRP3 inflammasome formation and activation and thus ameliorates steatohepatitis or NASH.